Oaktree Acquisition Corp. III Life Sciences (OACC) EBT (2025 - 2026)
Oaktree Acquisition Corp. III Life Sciences (OACC) reported EBT of $1.4 million for Q1 2026, down 15.96% on a YoY basis from $1.7 million in Q1 2025, and down 22.07% quarter-over-quarter from $1.8 million in Q4 2025.
Oaktree Acquisition Corp. III Life Sciences (OACC) EBT (2025 - 2026) Analysis & Trends
Oaktree Acquisition Corp. III Life Sciences has reported EBT for 2 years, with the latest figure at $1.4 million in Q1 2026.
- For the quarter ending Q1 2026, EBT fell 15.96% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $7.0 million (changed N/A YoY), and the FY2025 full-year result was $7.3 million, up 489.27% from the prior year.
- EBT for Q1 2026 stood at $1.4 million, down from $1.8 million in the prior quarter.
- The five-year high for EBT was $2.0 million in Q3 2025, with the low at $1.4 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | 3.87 Mn |
| 2 | Berto Acquisition | 312.46 Mn | 312.46 Mn | - | 2.22 Mn |
| 3 | Centurion Acquisition | 311.65 Mn | 311.65 Mn | - | 2.52 Mn |
| 4 | GP-Act III Acquisition | 311.36 Mn | 311.36 Mn | - | 2.89 Mn |
| 5 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | 1.49 Mn |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | 2.75 Mn |
| 7 | Bold Eagle Acquisition | 275.54 Mn | 275.54 Mn | - | 2.17 Mn |
| 8 | Soulpower Acquisition | 264.91 Mn | 264.91 Mn | - | 2.95 Mn |
| 9 | BTC Development | 262.16 Mn | 262.16 Mn | - | 1.70 Mn |
| 10 | Oaktree Acquisition Corp. III Life Sciences | 57.34 Mn | 57.34 Mn | - | 1.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.39 Mn |
| Dec 31, 2025 | 1.79 Mn |
| Sep 30, 2025 | 1.97 Mn |
| Jun 30, 2025 | 1.87 Mn |
| Mar 31, 2025 | 1.66 Mn |